Medtronic Launches the First Ever Artificial Intelligence-Based System for Colonoscopy
Medtronic’s GI Genius Intelligent Endoscopy Module uses artificial intelligence to detect colorectal polyps.
Medtronic has taken a major step forward in the fight against colorectal cancer through intelligent endoscopy. Colorectal cancer is the third most common cancer worldwide, with 1.8 million new cases reported annually. Therefore, Medtronic’s GI Genius module uses artificial intelligence to highlight the presence of pre-cancerous lesions with a visual marker in real-time.
Intelligent endoscopy for early detection
Medtronic’s innovative use of AI in gastroenterology will improve the quality and reliability of colonoscopies. It is, therefore, a good example of the integration of advanced technology inside the day-to-day practice.
Prof. Alessandro Repici, head of gastroenterology at Humanitas Hospital in Rozzano (Milan). – “The GI Genius module can be extremely precise in identifying lesions in the colonic mucosa that can be difficult to detect and may have been missed. This change in daily practice has the potential to improve diagnosis and overall outcomes for patients that may have colorectal cancer.”
Giovanni Di Napoli, vice president and general manager of the Gastrointestinal & Hepatology business, Medtronics. – “The GI Genius module automatically detects polyps, including small flat polyps that may go undetected, thus increasing accuracy and reducing the risk of interval cancers which can occur between colonoscopies.”
In May 2019, Medtronics entered into a Collaboration Agreement with Cosmo Pharmaceuticals to start a research collaboration in Artificial Intelligence in GI to identify various technological solutions and associated business opportunities.
AI-based intelligent endoscopy: manufacture by Cosmo Pharmaceuticals
Cosmo Pharmaceuticals manufactures the AI software and device for this application. Medtronic will bring this technology to the market through a worldwide distribution agreement with Cosmo. However, the GI Genius intelligent endoscopy module does not have FDA clearance. Therefore it is not available for sale in the United States.
Yale University Researchers Say AI Will Weigh Stomach (GI) Disorders
Last month, Yale University researchers determined that artificial intelligence could provide patients with stomach disorders better treatment. AI can reduce wait times, costs, and other burdens on hospitals. It may also allow doctors to evaluate and treat patients at home.
Latest Alternative Investment News
Evidation Health’s Achievement platform collects everyday health data for use in innovative research and health platforms. Giving due emphasis to user privacy and controlled, permissioned health data, the platform gathers…
MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL), Ava Robotics, and the Greater Boston Food Bank (GBFB) collaborated on a robotic solution to the problem of disinfecting a large area…
Alternative Investments: TrueMark Investments Launches A Structured Outcome ETF That Tracks the S&P 500 Index
TrueMark Investments has launched the TrueShares Structured Outcome (July) ETF (NYSEAMERICAN: JULZ) that offers investors exposure to the S&P 500 price index. The ETF is a “structured outcome” product, the…
The Supreme Court of India recently struck down a circular issued by the Reserve Bank of India that barred banks from serving crypto businesses such as traders, exchanges, or others….